Mountain Crest Acquisition Corp II
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $50M
- Underwriters
- SEC Filings
- 1832415
- Public Embarc Page
- https://embarc.com/capital/spac/1832415/MCAD/mountain-crest-acquisition
- IPO Ticker
- MCAD
SPAC Leadership
Information on the SPAC leadership.
- Chairman and Chief Executive OfficerDr. Suying Liu(Chairman/CEO, MCAC)
- Chief Financial Officer and DirectorDong Liu
- DirectorNelson Haight
- DirectorTodd Milbourn
- DirectorWenhua Zhang
Target Information
Information on the SPAC target for merger.
- Company
- Better Therapeutics
- Presentation
- Investor Presentation (SEC) on 2021-04-07
- Description
- Better Therapeutics is "a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases."